Group 1 - The core viewpoint of the news is that Weigao Blood Purification experienced a decline in stock price and trading volume on September 22, with a net financing outflow [1] - On September 22, Weigao Blood Purification had a financing buy amount of 6.24 million yuan and a financing repayment of 8.39 million yuan, resulting in a net financing buy of -2.15 million yuan [1] - As of September 22, the total balance of margin trading for Weigao Blood Purification was 104 million yuan, accounting for 7.04% of its circulating market value [1] Group 2 - As of June 30, the number of shareholders for Weigao Blood Purification was 31,400, a decrease of 47.45% compared to the previous period [2] - The average circulating shares per person increased by 90.29% to 1,213 shares [2] - For the first half of 2025, Weigao Blood Purification achieved an operating income of 1.765 billion yuan, a year-on-year increase of 8.52%, and a net profit attributable to shareholders of 220 million yuan, a year-on-year increase of 10.11% [2]
威高血净9月22日获融资买入623.98万元，融资余额1.04亿元